Evaluation of the Correlation between Regional Retinal Ganglion Cell Damage and Visual Field Sensitivity in Patients with Advanced Glaucoma.
glaucoma
optical coherence tomography
retinal ganglion cell layer
standard automated perimetry
structure-function correlation
visual field
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
19 Aug 2022
19 Aug 2022
Historique:
received:
24
06
2022
revised:
24
07
2022
accepted:
14
08
2022
entrez:
26
8
2022
pubmed:
27
8
2022
medline:
27
8
2022
Statut:
epublish
Résumé
(1) Background: to investigate the correlation between structural (retinal ganglion cells and retinal nerve fibers) and functional alterations analyzed point-by-point in the central 10 degrees of the visual field of patients with advanced glaucoma using Humphrey 10-2 visual field tests. (2) Methods: Single-center prospective cohort study carried on from October 2018 to February 2019 at the Croix-Rousse hospital, Lyon, France. The primary outcome measure was the point-by-point correlation between retinal sensitivity (Humphrey 10-2) and retinal ganglion cell complex (GCC) thickness. (3) Results: 29 eyes of 27 patients were examined. Of these, 15 eyes had a mean deviation (MD) less than −20 dB. There were statistically significant linear relationships between GCC thickness and 10-2 visual field sensitivity for several points in the lower part of the visual field, with lower retinal sensitivity being associated with thicker GCC layers. There were no strong linear relationships or statistically significant correlations in the other regions of the visual field. For the patients with MD < −20 dB, there were statistically significant linear relationships between GCC thickness and 10-2 visual field sensitivity for several points in the superior nasal region. Retinal sensitivity was not correlated with retinal nerve fibre layer thickness. (4) Conclusions: In this study of patients with advanced glaucoma, GCC thickness was linearly associated with 10-2 visual field sensitivity in certain regions, negatively for patients with less-severe glaucoma. The initial thickening raises questions about the apoptosis mechanism, while the thinning observed in the most severe cases is consistent with the ganglion cell death identified on visual field tests.
Identifiants
pubmed: 36013117
pii: jcm11164880
doi: 10.3390/jcm11164880
pmc: PMC9409684
pii:
doi:
Types de publication
Journal Article
Langues
eng
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Acta Ophthalmol. 2016 May;94(3):e211-9
pubmed: 26132774
Prog Retin Eye Res. 2017 Mar;57:46-75
pubmed: 28012881
Ophthalmology. 2000 Oct;107(10):1809-15
pubmed: 11013178
Invest Ophthalmol Vis Sci. 2013 Sep 09;54(9):6074-82
pubmed: 23882689
Arch Ophthalmol. 1979 May;97(5):948-50
pubmed: 109068
Am J Ophthalmol. 2010 Dec;150(6):825-33
pubmed: 20851372
J Glaucoma. 2019 Dec;28(12):1079-1085
pubmed: 31478953
Invest Ophthalmol Vis Sci. 2005 Jun;46(6):2012-7
pubmed: 15914617
J Comp Neurol. 1990 Oct 1;300(1):5-25
pubmed: 2229487
Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1972;184(2):126-50
pubmed: 4556291
Ophthalmology. 2017 Oct;124(10):1466-1474
pubmed: 28549518
Invest Ophthalmol Vis Sci. 2009 Feb;50(2):974-9
pubmed: 18952921
Br J Ophthalmol. 2012 Dec;96(12):1452-5
pubmed: 23018425
Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6344-51
pubmed: 26436887
Am J Ophthalmol. 2017 Mar;175:37-44
pubmed: 27914978
Prog Retin Eye Res. 2015 Jan;44:1-14
pubmed: 25448921
Prog Retin Eye Res. 2013 Jan;32:1-21
pubmed: 22995953
Vision Res. 2007 Oct;47(22):2901-11
pubmed: 17320143
Invest Ophthalmol Vis Sci. 2002 Aug;43(8):2654-9
pubmed: 12147599
Arch Ophthalmol. 2011 Dec;129(12):1529-36
pubmed: 22159673
Arch Ophthalmol. 2002 Jun;120(6):714-20; discussion 829-30
pubmed: 12049575
Prog Retin Eye Res. 2012 Mar;31(2):152-81
pubmed: 22155051
Invest Ophthalmol Vis Sci. 2002 Apr;43(4):1088-94
pubmed: 11923250
Ophthalmology. 2016 May;123(5):930-8
pubmed: 27016459
Br J Ophthalmol. 2015 Jun;99(6):732-7
pubmed: 25492547
Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3662-8
pubmed: 17652736
Ophthalmology. 1999 Apr;106(4):653-62
pubmed: 10201583
Control Clin Trials. 1994 Aug;15(4):299-325
pubmed: 7956270
Br J Ophthalmol. 2017 May;101(5):73-127
pubmed: 28424171
J Glaucoma. 2019 Nov;28(11):1006-1011
pubmed: 31567911
Arch Ophthalmol. 2002 Oct;120(10):1268-79
pubmed: 12365904
Prog Retin Eye Res. 2007 Nov;26(6):688-710
pubmed: 17889587